Health Partnership Schemes: Funding

Debate between Lord Crisp and Lord Ahmad of Wimbledon

Monday 7th June 2021 Lords Chamber

[Lord Crisp (CB) [V]]

My Lords, I beg leave to ask the Question standing in my name on the Order Paper. In doing so, I declare my interest as patron of THET, the Tropical Health and Education Trust.

[The Minister of State, Foreign, Commonwealth and Development Office (Lord Ahmad of Wimbledon) (Con)]

My Lords, UK health professionals have made a substantial contribution to achieving global health goals in developing countries by giving their time voluntarily through health partnership schemes. However, the UK is facing its worst economic contraction in over 300 years and a budget deficit of close to £400 billion. Given the impact of the global pandemic on the economy, the Government have been forced to take tough but necessary decisions, including to close our UK Partnerships for Health Systems programme.

[Lord Crisp (CB) [V]]

I thank the noble Lord for that Answer. As he says, hundreds and maybe thousands of health professionals every year, voluntarily and in their own time, support their colleagues in low and middle-income countries with Covid and in all other kinds of areas. It is good for those countries and good for the NHS, because it provides training and development as well as learning; we learned so much during the Ebola epidemic. For the last 10 years Her Majesty’s Government have supported these schemes in some areas such as transport, and so on. They have been very positive but, as the noble Lord says, they have been cut completely. So I have two specific questions. In February, Her Majesty’s Government agreed or committed themselves to continue to support the partnership scheme in Myanmar, which is dealing with Covid but also the dreadful emergency. Will the Government honour that commitment? Secondly, how will the Government continue to support UK volunteers, who give and gain so much and who are great ambassadors for the UK, given the withdrawal of this scheme?

[Lord Ahmad of Wimbledon (Con)]

My Lords, on the noble Lord’s second point, I agree that our medical professionals play an incredible role around the world. Certainly, I am keen to explore with the noble Lord and key Ministers, including my colleague Minister Morton, to see how through the contributions we make to health through institutions such as the World Health Organization we can continue to leverage that expertise. On Myanmar specifically, of course with the coup the situation has been extremely difficult. The noble Lord is correct in saying that we are cancelling future activity on this particular programme, but we will fund a round of grants to support voluntary health partnerships working in Myanmar.

Covid-19: Surplus Vaccine Doses

Debate between Lord Crisp and Lord Ahmad of Wimbledon

Monday 22nd February 2021 Lords Chamber

[Lord Ahmad of Wimbledon (Con)]

My Lords, on the noble Baroness’s second point, the Government have made their position clear. It was a difficult decision, but a necessary one. Nevertheless, it still guarantees £10 billion of support this year. On support to Oxford University, our commitment to UK science has been a major contribution to being where we are on the global stage when it comes to vaccine distribution and research.

[Lord Crisp (CB) [V]]

My Lords, I congratulate the Government on this initiative and on their positive support for COVAX. I note that other countries are making their own unilateral offers. Will the Government, with their influence as president of the G7, take two further initiatives? Will they seek a commitment from G7 countries, and others if possible, to offer a vaccination to all vulnerable people and health and care workers in those 92 countries by a target date of, say, July 2022? Will they seek an agreement to waive parts of the TRIPS agreement on intellectual property so that there are no barriers restricting access to Covid-19 medicines, tools, devices and vaccines?

[Lord Ahmad of Wimbledon (Con)]

My Lords, on the noble Lord’s second point, Oxford and AstraZeneca have worked very closely on intellectual property. Indeed, close collaboration with the Serum Institute of India has allowed it to produce exactly the same vaccine in India. On his earlier point about COVAX and other countries, he will have noted that UK leadership—we used the first G7 summit led by the Prime Minister—resulted in major contributions to COVAX, not least $4 billion from the United States as well as from the European Commission and Germany.

Official Development Assistance

Debate between Lord Crisp and Lord Ahmad of Wimbledon

Thursday 26th November 2020 Lords Chamber

[Lord Ahmad of Wimbledon (Con)]

My Lords, my noble friend is right: we will remain one of the most generous G7 donors, spending more of our national income, in percentage terms, than the United States, Japan, Canada or Italy. I further assure my noble friend that we stand very firmly in ensuring that, when we look at poverty alleviation, fighting famine, our commitment through the various vaccine summits we have held and the importance of our COP 26 presidency —with the commitment we have made on climate finance —we stand ready to continue to meet our obligations both domestically and internationally.

[Lord Crisp (CB) [V]]

My Lords, this cut is short-sighted and mean-spirited; it will damage our national interests and scar the lives of millions. Disturbingly, there is no end point. We are all aware of the financial situation, but what other options were considered? The UK will spend billions on vaccines from its aid budget and elsewhere for people in low and middle incomes as well as its own citizens. Could it not have made a virtue of this by using the aid budget to commit to vaccinations for all, not just making a cut but demonstrating UK leadership on the protection of the world’s health and providing a welcome boost for UK science and technology? Was this considered, and why was it not done? If the Minister does not know the answer, I would be grateful for a letter.

[Lord Ahmad of Wimbledon (Con)]

I do not agree with the noble Lord. On the specific issue of the vaccine, he will recall that, when my right honourable friend the Prime Minister returned from his own challenge with Covid-19, the first summit he chaired was the Gavi summit, which committed £330 million per year to other vaccines. As the Minister responsible for south Asia, I know that issues of polio still impact vulnerable communities in places such as Afghanistan and Pakistan. Equally, we have led from the front on the importance of the Covid-19 vaccine, with a commitment of £571 million to the COVAX Facility. The Covid-19 challenge, along with climate finance, are arguably the two biggest challenges facing the world today and through 2021, and we have shown leadership on both and will continue to do so.